annual EBITDA:
$2.68B-$18.51B(-87.35%)Summary
- As of today (July 7, 2025), BMA annual EBITDA is $2.68 billion, with the most recent change of -$18.51 billion (-87.35%) on December 31, 2024.
- During the last 3 years, BMA annual EBITDA has fallen by -$5.37 billion (-66.70%).
- BMA annual EBITDA is now -87.35% below its all-time high of $21.19 billion, reached on December 31, 2023.
Performance
BMA EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
$385.22M-$248.75M(-39.24%)Summary
- As of today (July 7, 2025), BMA quarterly EBITDA is $385.22 million, with the most recent change of -$248.75 million (-39.24%) on March 1, 2025.
- Over the past year, BMA quarterly EBITDA has dropped by -$1.37 billion (-78.11%).
- BMA quarterly EBITDA is now -97.06% below its all-time high of $13.10 billion, reached on December 31, 2022.
Performance
BMA quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$1.61B-$1.37B(-46.10%)Summary
- As of today (July 7, 2025), BMA TTM EBITDA is $1.61 billion, with the most recent change of -$1.37 billion (-46.10%) on March 1, 2025.
- Over the past year, BMA TTM EBITDA has dropped by -$14.56 billion (-90.06%).
- BMA TTM EBITDA is now -93.30% below its all-time high of $23.99 billion, reached on September 30, 2023.
Performance
BMA TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
BMA EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -87.3% | -78.1% | -90.1% |
| 3 y3 years | -66.7% | -45.4% | -37.5% |
| 5 y5 years | -39.4% | -21.7% | +74.7% |
BMA EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -87.3% | at low | -97.1% | +265.0% | -93.3% | at low |
| 5 y | 5-year | -87.3% | at low | -97.1% | +265.0% | -93.3% | +74.7% |
| alltime | all time | -87.3% | at low | -97.1% | +265.0% | -93.3% | +356.1% |
BMA EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $385.22M(-39.2%) | $1.61B(-46.1%) |
| Dec 2024 | $2.68B(-87.3%) | $633.97M(+31.6%) | $2.98B(-66.7%) |
| Sep 2024 | - | $481.92M(+356.6%) | $8.95B(-24.9%) |
| Jun 2024 | - | $105.54M(-94.0%) | $11.93B(-26.3%) |
| Mar 2024 | - | $1.76B(-73.4%) | $16.17B(-7.5%) |
| Dec 2023 | $21.19B(+3.6%) | $6.61B(+91.3%) | $17.49B(-27.1%) |
| Sep 2023 | - | $3.45B(-20.6%) | $23.99B(+8.0%) |
| Jun 2023 | - | $4.35B(+41.4%) | $22.20B(+18.1%) |
| Mar 2023 | - | $3.08B(-76.5%) | $18.80B(+14.4%) |
| Dec 2022 | $20.45B(+153.9%) | $13.10B(+683.8%) | $16.43B(+294.9%) |
| Sep 2022 | - | $1.67B(+76.5%) | $4.16B(+36.3%) |
| Jun 2022 | - | $946.96M(+34.2%) | $3.05B(+18.7%) |
| Mar 2022 | - | $705.39M(-15.6%) | $2.57B(+10.2%) |
| Dec 2021 | $8.05B | $835.55M(+48.0%) | $2.33B(+15.1%) |
| Sep 2021 | - | $564.47M(+20.9%) | $2.03B(+2.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | $466.85M(+0.0%) | $1.98B(+2.0%) |
| Mar 2021 | - | $466.84M(-11.7%) | $1.94B(-1.3%) |
| Dec 2020 | $4.39B(-0.8%) | $528.51M(+2.7%) | $1.96B(+36.8%) |
| Sep 2020 | - | $514.57M(+20.2%) | $1.43B(+55.9%) |
| Jun 2020 | - | $428.03M(-13.0%) | $919.90M(+87.0%) |
| Mar 2020 | - | $491.87M(-68.2%) | $491.87M(-82.0%) |
| Dec 2019 | $4.43B(+37.4%) | - | - |
| Dec 2018 | $3.22B(+6.1%) | $1.55B(+323.0%) | $2.73B(-8.8%) |
| Sep 2018 | - | $366.16M(-1.9%) | $3.00B(-1.6%) |
| Jun 2018 | - | $373.12M(-16.3%) | $3.05B(-0.1%) |
| Mar 2018 | - | $445.66M(-75.4%) | $3.05B(+3.2%) |
| Dec 2017 | $3.04B | $1.81B(+336.9%) | $2.96B(+158.5%) |
| Sep 2017 | - | $415.05M(+10.2%) | $1.14B(+56.9%) |
| Jun 2017 | - | $376.79M(+7.0%) | $729.03M(+107.0%) |
| Mar 2017 | - | $352.24M | $352.24M |
FAQ
- What is Banco Macro S.A. annual EBITDA?
- What is the all time high annual EBITDA for Banco Macro S.A.?
- What is Banco Macro S.A. annual EBITDA year-on-year change?
- What is Banco Macro S.A. quarterly EBITDA?
- What is the all time high quarterly EBITDA for Banco Macro S.A.?
- What is Banco Macro S.A. quarterly EBITDA year-on-year change?
- What is Banco Macro S.A. TTM EBITDA?
- What is the all time high TTM EBITDA for Banco Macro S.A.?
- What is Banco Macro S.A. TTM EBITDA year-on-year change?
What is Banco Macro S.A. annual EBITDA?
The current annual EBITDA of BMA is $2.68B
What is the all time high annual EBITDA for Banco Macro S.A.?
Banco Macro S.A. all-time high annual EBITDA is $21.19B
What is Banco Macro S.A. annual EBITDA year-on-year change?
Over the past year, BMA annual EBITDA has changed by -$18.51B (-87.35%)
What is Banco Macro S.A. quarterly EBITDA?
The current quarterly EBITDA of BMA is $385.22M
What is the all time high quarterly EBITDA for Banco Macro S.A.?
Banco Macro S.A. all-time high quarterly EBITDA is $13.10B
What is Banco Macro S.A. quarterly EBITDA year-on-year change?
Over the past year, BMA quarterly EBITDA has changed by -$1.37B (-78.11%)
What is Banco Macro S.A. TTM EBITDA?
The current TTM EBITDA of BMA is $1.61B
What is the all time high TTM EBITDA for Banco Macro S.A.?
Banco Macro S.A. all-time high TTM EBITDA is $23.99B
What is Banco Macro S.A. TTM EBITDA year-on-year change?
Over the past year, BMA TTM EBITDA has changed by -$14.56B (-90.06%)